1229620-82-9 Usage
Uses
Used in Pharmaceutical Industry:
(S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-yl acetate hydrochloride is used as a potential therapeutic agent for its interactions with biological systems. Its complex structure may allow it to target specific receptors or enzymes, making it a candidate for the development of new drugs.
Used in Biochemical Research:
In the field of biochemistry, (S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-yl acetate hydrochloride can be utilized as a research tool to study the interactions between small molecules and biological macromolecules, such as proteins or nucleic acids. This understanding can lead to the discovery of novel mechanisms of action and potential therapeutic targets.
Used in Chemical Synthesis:
(S)-6-(propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-yl acetate hydrochloride may also serve as a chemical intermediate in the synthesis of other complex organic compounds. Its unique functional groups and structural features can be exploited in the development of new synthetic routes and the creation of novel molecules with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1229620-82-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,9,6,2 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1229620-82:
(9*1)+(8*2)+(7*2)+(6*9)+(5*6)+(4*2)+(3*0)+(2*8)+(1*2)=149
149 % 10 = 9
So 1229620-82-9 is a valid CAS Registry Number.
1229620-82-9Relevant academic research and scientific papers
PROCESS FOR THE PREPARATION OF (6S)-(-)-5,6,7,8-TETRAHYDRO-6-[PROPYL-(2-THIENYL)ETHYL]AMINO-1-NAPHTHOL (ROTIGOTINE)
-
Page/Page column 9-10, (2010/06/22)
The present invention describes a novel process for the preparation of (6S)-(-)-5,6,7,8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol (Rotigotine) comprising: (a) acetylating (S)-(-)-5-hydroxy-N-n-propyl-2-aminotetraline to afford the acetate; (b) reacting this acetate, (-)-5-acetoxy- N-n-propyl-2-aminotetraline, with 2-(2-thienyl)ethanol 2- nitrobenzenesulfonate; (d) hydrolyzing (6S)-(-)-1-acetoxy-5, 6,7,8- tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthalene to afford (6S)-(- )-5, 6, 7, 8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol (Rotigotine) and (d) purifying rotigotine either by the acetylation reaction and subsequent hydrolysis of the formed acetate or by salification of rotigotine through hydrochloride or hydrobromide formation and subsequent base release. Rotigotine is a dopamine agonist and is indicated for the treatment of Parkinson's disease.
